Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Halozyme Announces Phase 2 Study in Advanced Pancreas Cancer Meets Key Endpoints

americanpharmaceuticalreviewJanuary 06, 2017

Tag: Halozyme , Advanced Pancreas Cancer

PharmaSources Customer Service